NASDAQ:ICUI

ICU Medical (ICUI) Stock Forecast, Price & News

$117.00

+1.73 (+1.50%)

(As of 09/27/2023 ET)

Compare

Today's Range: $115.17
▼
$118.26
50-Day Range: $115.27
▼
$178.18
52-Week Range: $114.04
▼
$212.43

Volume: 191,270 shs
Average Volume: 190,040 shs
Market Capitalization: $2.82 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $216.00

ICU Medical MarketRank™ Forecast

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 84.6% Upside
$216.00 Price Target
Short Interest: Healthy
5.43% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.47
Upright™ Environmental Score
News Sentiment: 1.01
Based on 3 Articles This Week
Insider Trading: Selling Shares
$6.28 M Sold Last Quarter
Proj. Earnings Growth: 11.39%
From $5.18 to $5.77 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.42 out of 5 stars

Medical Sector

240th out of 976 stocks

Surgical & Medical Instruments Industry

32nd out of 98 stocks

3.0

Analyst's Opinion

Consensus Rating
ICU Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $216.00, ICU Medical has a forecasted upside of 84.6% from its current price of $117.00.
Amount of Analyst Coverage
ICU Medical has received no research coverage in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
5.43% of the float of ICU Medical has been sold short.
Short Interest Ratio / Days to Cover
ICU Medical has a short interest ratio ("days to cover") of 5.5.
Change versus previous month
Short interest in ICU Medical has recently decreased by 5.17%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
ICU Medical does not currently pay a dividend.
Dividend Growth
ICU Medical does not have a long track record of dividend growth.

3.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
ICU Medical has received a 52.01% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Intravenous therapy equipment", "Catheters", and "Parenteral (intravenous) nutrition formulations" products. See details.
Environmental Sustainability
The Environmental Impact score for ICU Medical is -1.47.

3.3

News and Social Media Coverage

News Sentiment
ICU Medical has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for ICU Medical this week, compared to 2 articles on an average week.
MarketBeat Follows
2 people have added ICU Medical to their MarketBeat watchlist in the last 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ICU Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,284,524.00 in company stock.
Percentage Held by Insiders
Only 7.50% of the stock of ICU Medical is held by insiders.
Percentage Held by Institutions
91.49% of the stock of ICU Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for ICU Medical are expected to grow by 11.39% in the coming year, from $5.18 to $5.77 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of ICU Medical is -57.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of ICU Medical is -57.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
ICU Medical has a P/B Ratio of 1.34. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About ICU Medical (NASDAQ:ICUI) Stock

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

ICUI Price History

30 days | 90 days | 365 days | Advanced Chart

ICUI Stock News Headlines

September 25, 2023 | finance.yahoo.com

Do Options Traders Know Something About ICU Medical (ICUI) Stock We Don't?

September 12, 2023 | benzinga.com

ICU Medical Chief Operating Officer Trades Company's Stock

September 28, 2023 | UNKNOWN (Ad)

A Bio-Tech Stock That Has Been Growing Like Crazy!

Recent News for This One Bio-Tech Has Us All Getting Excited. Sign Up today And Learn More

September 12, 2023 | finance.yahoo.com

Insider Sell: Christian Voigtlander Sells 6,850 Shares of ICU Medical Inc

September 5, 2023 | finance.yahoo.com

ICU Medical to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference

August 29, 2023 | marketwatch.com

ICU Medical Gets FDA Clearance for Infusion Pump-Software Combo

August 29, 2023 | finance.yahoo.com

ICU Medical Receives FDA Clearance for Plum Duo™ Infusion Pump and LifeShield™ Infusion Safety Software

August 21, 2023 | seekingalpha.com

ICU Medical: Continued Disappointments

September 28, 2023 | UNKNOWN (Ad)

A Bio-Tech Stock That Has Been Growing Like Crazy!

Recent News for This One Bio-Tech Has Us All Getting Excited. Sign Up today And Learn More

August 9, 2023 | finance.yahoo.com

ICU Medical, Inc. (NASDAQ:ICUI) Q2 2023 Earnings Call Transcript

August 8, 2023 | finanznachrichten.de

ICU Medical, Inc.: ICU Medical Announces Second Quarter 2023 Results and Narrows Fiscal Year 2023 Guidance Ranges

August 8, 2023 | markets.businessinsider.com

ICU Medical Q2 Earnings Summary

August 8, 2023 | finance.yahoo.com

ICU Medical Announces Second Quarter 2023 Results and Narrows Fiscal Year 2023 Guidance Ranges

August 8, 2023 | finance.yahoo.com

ICU Medical (ICUI) Beats Q2 Earnings Estimates

July 29, 2023 | msn.com

Critical care unit at Ernakulam government medical college remains a non-starter

July 24, 2023 | finance.yahoo.com

ICU Medical Announces Time of Second Quarter 2023 Earnings Conference Call

July 14, 2023 | news.yahoo.com

Ty Pennington details visit to ICU due to abscess that was closing off his airway

June 15, 2023 | msn.com

ICU Medical: Challenges To Profit Growth Clearly Identifiable

May 17, 2023 | finanznachrichten.de

ICU Medical, Inc.: ICU Medical Announces First Quarter 2023 Results

May 11, 2023 | benzinga.com

ICU Medical shares are trading higher after the company reported better-than-expected Q1 results.

May 10, 2023 | msn.com

The Medical Care That Helps No One

May 10, 2023 | msn.com

‘This is what I’m meant to do,’ ICU Nurse shares his passion for the profession

May 10, 2023 | marketwatch.com

Acute Care Needleless Connector Market Likely to Enjoy Remarkable Growth with ICU Medical, Becton Dickinson, B.Braun, CareFusion

May 10, 2023 | finance.yahoo.com

Insiders See US$4.5m Investment In ICU Medical Jump Last Week \

May 9, 2023 | msn.com

Keybanc Maintains ICU Medical (ICUI) Overweight Recommendation

May 9, 2023 | finance.yahoo.com

Q1 2023 ICU Medical Inc Earnings Call

May 9, 2023 | seekingalpha.com

ICU Medical, Inc. 2023 Q1 - Results - Earnings Call Presentation

See More Headlines

Receive ICUI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.

ICUI Company Calendar

Last Earnings: 8/07/2023
Today: 9/28/2023
Next Earnings (Estimated): 11/06/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: Health Care Supplies
Sector: Medical
Current Symbol: NASDAQ:ICUI
CUSIP: 44930G10
CIK: 883984
Web: www.icumed.com
Phone: (949) 366-2183
Fax: 949-366-8368
Employees: 14,500
Year Founded: 1984

Price Target and Rating

Average Stock Price Forecast: $216.00
High Stock Price Forecast: $216.00
Low Stock Price Forecast: $216.00
Forecasted Upside/Downside: +84.6%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($2.02)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 22.59
P/E Growth: N/A
Net Income: $-74,290,000.00
Net Margins: -2.11%
Pretax Margin: -3.44%
Return on Equity: 6.93%
Return on Assets: 3.22%

Debt

Debt-to-Equity Ratio: 0.76
Current Ratio: 2.57
Quick Ratio: 0.97

Sales & Book Value

Annual Sales: $2.29 billion
Price / Sales: 1.23
Cash Flow: $16.60 per share
Price / Cash Flow: 7.05
Book Value: $87.15 per share
Price / Book: 1.34

Miscellaneous

Outstanding Shares: 24,100,000
Free Float: 22,293,000
Market Cap: $2.82 billion
Optionable: Optionable
Beta: 0.64

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Vivek Jain (Age 51)
CEO & Chairman
Comp: $1.16M

Mr. Brian Michael Bonnell (Age 49)
CFO & Treasurer
Comp: $618.92k

Mr. Christian B. Voigtlander (Age 54)
Chief Operating Officer
Comp: $651.42k

Ms. Virginia Ruth Sanzone (Age 48)
Corp. VP, Gen. Counsel, Sec. & Compliance Officer
Comp: $552.73k

Clay Fradd
Corp. VP of HR

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ICUI Stock - Frequently Asked Questions

Should I buy or sell ICU Medical stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ICUI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ICUI, but not buy additional shares or sell existing shares.
View ICUI analyst ratings or view top-rated stocks.
What is ICU Medical's stock price forecast for 2023?: 1 Wall Street research analysts have issued 1 year target prices for ICU Medical's stock. Their ICUI share price forecasts range from $216.00 to $216.00. On average, they anticipate the company's stock price to reach $216.00 in the next year. This suggests a possible upside of 84.6% from the stock's current price.
View analysts price targets for ICUI or view top-rated stocks among Wall Street analysts.
How have ICUI shares performed in 2023?: ICU Medical's stock was trading at $157.48 at the beginning of 2023. Since then, ICUI stock has decreased by 25.7% and is now trading at $117.00.
View the best growth stocks for 2023 here.
Are investors shorting ICU Medical?: ICU Medical saw a decrease in short interest in September. As of September 15th, there was short interest totaling 1,100,000 shares, a decrease of 5.2% from the August 31st total of 1,160,000 shares. Based on an average trading volume of 199,700 shares, the short-interest ratio is currently 5.5 days. Approximately 5.4% of the shares of the company are sold short.
View ICU Medical's Short Interest.
When is ICU Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our ICUI earnings forecast.
How were ICU Medical's earnings last quarter?: ICU Medical, Inc. (NASDAQ:ICUI) posted its earnings results on Monday, August, 7th. The medical instruments supplier reported $1.58 EPS for the quarter, topping analysts' consensus estimates of $1.15 by $0.43. The medical instruments supplier earned $549.31 million during the quarter, compared to analysts' expectations of $562.90 million. ICU Medical had a negative net margin of 2.11% and a positive trailing twelve-month return on equity of 6.93%.
What ETFs hold ICU Medical's stock?: ETFs with the largest weight of ICU Medical (NASDAQ:ICUI) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), Fidelity Disruptive Medicine ETF (FMED) and Principal Healthcare Innovators ETF (BTEC) and
What guidance has ICU Medical issued on next quarter's earnings?: ICU Medical issued an update on its FY23 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of $6.00-6.85 for the period, compared to the consensus EPS estimate of $6.70.

What is Vivek Jain's approval rating as ICU Medical's CEO?: 81 employees have rated ICU Medical Chief Executive Officer Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among the company's employees.
What other stocks do shareholders of ICU Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and Company (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).
What is ICU Medical's stock symbol?: ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."
Who are ICU Medical's major shareholders?: ICU Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.12%), JPMorgan Chase & Co. (3.00%), Victory Capital Management Inc. (2.66%), State Street Corp (2.52%), Segall Bryant & Hamill LLC (1.54%) and Allspring Global Investments Holdings LLC (1.34%). Insiders that own company stock include Christian B Voigtlander, Daniel Woolson, Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends.
How do I buy shares of ICU Medical?: Shares of ICUI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is ICU Medical's stock price today?: One share of ICUI stock can currently be purchased for approximately $117.00.
How much money does ICU Medical make?: ICU Medical (NASDAQ:ICUI) has a market capitalization of $2.82 billion and generates $2.29 billion in revenue each year. The medical instruments supplier earns $-74,290,000.00 in net income (profit) each year or ($2.02) on an earnings per share basis.
How many employees does ICU Medical have?: The company employs 14,500 workers across the globe.
How can I contact ICU Medical?: ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The official website for the company is www.icumed.com. The medical instruments supplier can be reached via phone at (949) 366-2183, via email at ir@icumed.com, or via fax at 949-366-8368.

This page (NASDAQ:ICUI) was last updated on 9/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial